Literature DB >> 2304148

CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1.

X L Li1, T Moudgil, H V Vinters, D D Ho.   

Abstract

One neuronal cell line (SK-N-MC) was found to be susceptible to productive infection by multiple isolates of the human immunodeficiency virus type 1 (HIV-1). Characterization of SK-N-MC cells showed that these cells are neuroectodermal in origin in that they express dopamine hydroxylase, catecholamines, neuron-specific enolase, and neurofilaments. Despite their susceptibility to HIV-1 infection, SK-N-MC cells had no detectable CD4 and this infection was not blocked by anti-CD4 monoclonal antibodies (OKT4A, Leu3A) or recombinant soluble CD4. These experiments demonstrated that certain cells of neuroectodermal origin are susceptible to infection in vitro by HIV-1 via a CD4-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304148      PMCID: PMC249262     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

Authors:  A Traunecker; W Lüke; K Karjalainen
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.

Authors:  L A Lasky; G Nakamura; D H Smith; C Fennie; C Shimasaki; E Patzer; P Berman; T Gregory; D J Capon
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.

Authors:  S Dewhurst; K Sakai; J Bresser; M Stevenson; M J Evinger-Hodges; D J Volsky
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Infection of the retina by human immunodeficiency virus type I.

Authors:  R J Pomerantz; D R Kuritzkes; S M de la Monte; T R Rota; A S Baker; D Albert; D H Bor; E L Feldman; R T Schooley; M S Hirsch
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

6.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

Authors:  M Kowalski; J Potz; L Basiripour; T Dorfman; W C Goh; E Terwilliger; A Dayton; C Rosen; W Haseltine; J Sodroski
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

7.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

8.  Human immunodeficiency virus (HIV) infection of the uterine cervix.

Authors:  R J Pomerantz; S M de la Monte; S P Donegan; T R Rota; M W Vogt; D E Craven; M S Hirsch
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

9.  Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.

Authors:  D D Ho; J C Kaplan; I E Rackauskas; M E Gurney
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

10.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

View more
  41 in total

1.  The 'ACCIDENTAL NEUROPATHOLOGIST'-PERSPECTIVES on 40 years in Neuropathology.

Authors:  Harry V Vinters
Journal:  Free Neuropathol       Date:  2020-08-25

2.  Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system.

Authors:  C Gemma; E M Smith; T K Hughes; M R Opp
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

3.  A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.

Authors:  M Shahabuddin; G Bentsman; B Volsky; I Rodriguez; D J Volsky
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Authors:  N Thieblemont; N Haeffner-Cavaillon; A Ledur; J L'Age-Stehr; H W Ziegler-Heitbrock; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85.

Authors:  C Bova-Hill; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.

Authors:  Y Tani; E Donoghue; S Sharpe; E Boone; H C Lane; S Zolla-Pazner; D I Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism.

Authors:  A V Moses; F E Bloom; C D Pauza; J A Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Authors:  Richard D Kensinger; Bradley J Catalone; Fred C Krebs; Brian Wigdahl; Cara-Lynne Schengrund
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Persistent inapparent HIV-1 infection of human neuroblastoma cells.

Authors:  M Vesanen; T Linna; A Vaheri
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.